Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review
Open Access
- 29 November 2024
- journal article
- review article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (12) , 292
Abstract
Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease’s burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with prevalence varying across countries and age groups. Newborn screening programs have highlighted the high prevalence of SCD at birth, emphasizing the need for early diagnosis and intervention. The clinical manifestations of SCD in Africa are multifaceted, encompassing acute complications like vaso-occlusive crises, acute chest syndrome, and stroke, as well as chronic complications such as organ damage and leg ulcers. Biological factors, including fetal hemoglobin levels, and demographic factors, like age and sex, influence disease severity and outcomes. The management of SCD in Africa faces numerous challenges. Limited access to resources, including diagnostic tools, medications, and trained healthcare professionals, hinders optimal care. The high cost of advanced therapies further restricts patient access. Cultural stigma and a lack of awareness create additional barriers to effective management. To address these challenges, early diagnosis through newborn screening programs and point-of-care testing is crucial. Comprehensive care models, including hydroxyurea therapy, pain management, and patient education, are essential for improving outcomes. Collaboration with international networks and leveraging local resources can enhance the sustainability of SCD programs. In conclusion, SCD significantly impacts African populations. Overcoming the challenges associated with its management requires addressing resource limitations, affordability issues, and cultural barriers. Early diagnosis, comprehensive care models, and ongoing research focused on affordability and accessibility are crucial for improving the lives of individuals living with SCD in Africa.Keywords
This publication has 61 references indexed in Scilit:
- Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in KinshasaeJHaem, 2023
- Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challengesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- Determinants of severity in sickle cell diseaseBlood Reviews, 2022
- Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and careThe Lancet Haematology, 2021
- Transfusion and sickle cell anemia in AfricaTransfusion Clinique et Biologique, 2021
- Empowering newborn screening programs in African countries through establishment of an international collaborative effortJournal of Community Genetics, 2020
- Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria databaseBlood Cells, Molecules, and Diseases, 2020
- Physicians' Perception of Sickle-cell Disease PainJournal of the National Medical Association, 2016
- Management of sickle cell disease from childhood through adulthoodBlood Reviews, 2013
- Infection in sickle cell disease: A reviewInternational Journal of Infectious Diseases, 2010